Tags

Type your tag names separated by a space and hit enter

Tocilizumab for COVID-19: a real 'miracle drug'?
Infect Dis (Lond). 2020 09; 52(9):681-682.ID

Links

Publisher Full Text

Authors+Show Affiliations

Nasim S
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Hashmi SH
NYU Grossman School of Medicine, New York City, NY, USA.
Azim D
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Kumar S
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Nasim J
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.

MeSH

Antibodies, Monoclonal, HumanizedBetacoronavirusCOVID-19Coronavirus InfectionsDisease ProgressionHumansPandemicsPneumonia, ViralRetrospective StudiesRisk FactorsSARS-CoV-2

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32644027

Citation

Nasim, Sundus, et al. "Tocilizumab for COVID-19: a Real 'miracle Drug'?" Infectious Diseases (London, England), vol. 52, no. 9, 2020, pp. 681-682.
Nasim S, Hashmi SH, Azim D, et al. Tocilizumab for COVID-19: a real 'miracle drug'? Infect Dis (Lond). 2020;52(9):681-682.
Nasim, S., Hashmi, S. H., Azim, D., Kumar, S., & Nasim, J. (2020). Tocilizumab for COVID-19: a real 'miracle drug'? Infectious Diseases (London, England), 52(9), 681-682. https://doi.org/10.1080/23744235.2020.1780307
Nasim S, et al. Tocilizumab for COVID-19: a Real 'miracle Drug'. Infect Dis (Lond). 2020;52(9):681-682. PubMed PMID: 32644027.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tocilizumab for COVID-19: a real 'miracle drug'? AU - Nasim,Sundus, AU - Hashmi,Shariq Haider, AU - Azim,Dua, AU - Kumar,Sohail, AU - Nasim,Jasia, Y1 - 2020/06/17/ PY - 2020/7/10/entrez PY - 2020/7/10/pubmed PY - 2020/7/15/medline SP - 681 EP - 682 JF - Infectious diseases (London, England) JO - Infect Dis (Lond) VL - 52 IS - 9 SN - 2374-4243 UR - https://www.unboundmedicine.com/medline/citation/32644027/Tocilizumab_for_COVID_19:_a_real_'miracle_drug' L2 - https://www.tandfonline.com/doi/abs/10.1080/23744235.2020.1780307 DB - PRIME DP - Unbound Medicine ER -